Filana Therapeutics, Inc. FLNA
0.54 USD -0.03 (-6.12%)
Nov 5, 2026, 10:25 AM EST
0.537 Day range 0.5831
0.537 52-week range 3.45
- YTD
- -72.88%
- 1 year
- -82.39%
- Market cap
- 25.94M
- EPS (ttm)
- -0.87
- YTD return
- -72.88%
- 1-year return
- -82.39%
- Volume
- 89.43K
- Avg volume
- 2.03M
- Open
- 0.57
- Previous close
- 0.572
- Day's range
- 0.537 – 0.5831
- 52-week range
- 0.537 – 3.45
5D -0.0670 (-10.13%)
Financials — quick view
FLNA Revenue — quarterly 0
FLNA Net income — quarterly -8.60M
FLNA EPS — quarterly -0.18
News
Filana Therapeutics Q3 EPS $(0.22) Beats $(0.24) Estimate 
Filana Therapeutics Announces A Study Published By Yale Researchers Of New Preclinical Research On Simufilam Examined Simufilam's Impacts In Human Cell Line To Eliminate Tuberous Sclerosis Complex 2 Gene To Model Cellular Changes 
Filana Therapeutics Announces Publication in Cells of Promising Preclinical Findings for Simufilam in TSC2-Deficient Cells 
Filana Therapeutics to Participate in the 2026 Maxim Growth Summit 
12 Health Care Stocks Moving In Thursday's Pre-Market Session 
12 Health Care Stocks Moving In Wednesday's After-Market Session - 12 Health Care Stocks Moving In Tuesday's After-Market Session
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
Positive FDA Decision Propels Rebranded Filana Therapeutics Epilepsy Research Forward 
Positive FDA Decision Propels Rebranded Filana Therapeutics Epilepsy Research Forward
Your note
Sign in to keep a note on FLNA — it syncs with the Stock Master app.